Saturday, February 7, 2026
StockstToday.com Logo
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

JP Morgan Analyst Revises Price Target for Chegg Following Performance Evaluation and Market Analysis

Elaine Mendonca by Elaine Mendonca
February 7, 2024
in Breaking News
0
Finance_Investment (2)
0
SHARES
9
VIEWS
Share on FacebookShare on Twitter

On February 6, 2024, JP Morgan analyst Doug Anmuth reaffirmed his Neutral rating on Chegg (NYSE:CHGG), but revised the price target to $9 from $10. Anmuth’s decision was driven by a comprehensive evaluation of the company’s performance and prevailing market conditions.

CHGG Stock Plummets 6.13%: Analyzing the Reasons and Long-Term Prospects

On February 6, 2024, CHGG stock had a disappointing performance, trading near the bottom of its 52-week range and below its 200-day simple moving average. The stock experienced a significant drop of 6.13% since the market last closed, closing at $8.73. However, it managed to rise slightly by $0.01 in after-hours trading. Investors should conduct thorough research and analysis to understand the underlying reasons for the stock’s decline and consider the long-term prospects of the company before making any investment decisions.

Chegg Inc. (CHGG) Stock Shows Mixed Financial Performance in 2024: Revenue Decline but Positive Growth in Q4

On February 6, 2024, Chegg Inc. (CHGG) stock experienced mixed results in terms of its financial performance. According to data sourced from CNN Money, Chegg’s total revenue for the past year stood at $716.29 million, a decrease of 6.6% compared to the previous year. However, in the fourth quarter of the same year, the company saw a positive growth of 19.09% with total revenue amounting to $187.99 million. In terms of net income, Chegg reported a figure of $18.18 million for the past year, a significant decrease of 93.18% compared to the previous year. However, in the fourth quarter, the net income held steady at $9.66 million. Looking at the earnings per share (EPS), Chegg reported a negative figure of -$0.34 for the past year, a decrease of 119.11% compared to the previous year. However, in the fourth quarter, the EPS increased by 151.33% to reach $0.08. Investors and analysts will likely closely monitor these figures to assess the company’s ability to sustain its growth and profitability in the future.

Tags: CHGG
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post

JP Morgan Upgrades BeiGene Ltd NASDAQ BGNE to Overweight Citing Strong Growth Potential

Finance_ Chart Down

Former Canadian Prime Ministers Hedge Fund Sparks Surge in Kohls Stock Price

Tech-Innovations

JP Morgan Analyst Revises Price Target for ON Semiconductor Amidst Global Chip Shortage

Recommended

CRWD stock news

Tower Research Capital LLC TRC Demonstrates Unwavering Confidence in CrowdStrike Holdings as Cybersecurity Leader

2 years ago
Efficiently Reporting an Absence on WalmartOne: A Step-by-Step Guide for Employees

Beacon Announces Interim Chief Financial Officer

2 years ago

Alaska Airlines Boeing 737 Investigation Missing Bolts and Safety Measures

2 years ago

Impressive Financial Performance for Kiniksa Pharmaceuticals

2 years ago

Categories

  • AI & Quantum Computing
  • Analysis
  • Analyst Ratings
  • Asian Markets
  • Automotive & E-Mobility
  • Banking & Insurance
  • Bitcoin
  • Blockchain
  • Bonds
  • Breaking News
  • Business & Industry Trends
  • Cannabis
  • Chemicals
  • Commodities
  • Consumer & Luxury
  • Crypto Stocks
  • Cryptocurrency
  • Cyber Security
  • DAX
  • Defense & Aerospace
  • Dividends
  • Dow Jones
  • E-Commerce
  • Earnings
  • Emerging Markets
  • Energy & Oil
  • ETF
  • Ethereum & Altcoins
  • European Markets
  • Forex
  • Gaming & Metaverse
  • Gold & Precious Metals
  • Healthcare
  • Hydrogen
  • Index
  • Industrial
  • Insider Trading
  • IPOs
  • Market Commentary
  • Market News
  • MDAX & SDAX
  • Mergers & Acquisitions
  • Nasdaq
  • Newsletter
  • Penny Stocks
  • Pharma & Biotech
  • Real Estate & REITs
  • Renewable Energy
  • S&P 500
  • Semiconductors
  • Space
  • Stock Picks
  • Stock Targets
  • Stocks
  • TecDAX
  • Tech & Software
  • Telecommunications
  • Trading & Momentum
  • Turnaround
  • Uncategorized
  • Value & Growth

Topics

Adobe Alibaba Alphabet Amazon AMD Apple ASML BioNTech Bitcoin Broadcom Coca-Cola Coinbase D-Wave Quantum Eli Lilly Fiserv IBM Intel Kraft Heinz Marvell Technology META Micron Microsoft MP Materials MSCI World ETF Newmont Mining NIO Novo Nordisk Nvidia Ocugen Opendoor Oracle Palantir PayPal Plug Power QuantumScape Robinhood Rocket Lab USA Strategy Super Micro Computer Synopsys Tesla Tilray Unitedhealth Uranium Energy Viking Therapeutics
No Result
View All Result

Highlights

Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment

Diginex Enters Critical Implementation Phase Following Strategic Moves

Deluxe Stock Gains Momentum on Successful Fintech Transition

Hydrofarm Holdings: Q4 2025 Earnings Report Date Approaches

Northeast Bancorp Reports Robust Loan Growth Amid Strong Quarterly Performance

Vir Biotechnology’s 2026 Pipeline: A Year of Pivotal Clinical Data

Trending

Universal Insurance Stock
Analysis

Universal Insurance Maintains Quarterly Payout Amid Sector Headwinds

by Rodolfo Hanigan
February 7, 2026
0

Universal Insurance Holdings has reaffirmed its commitment to shareholder returns, declaring its regular quarterly dividend despite a...

Embecta Stock

Embecta’s Q1 Performance Outpaces Analyst Forecasts

February 7, 2026
Camping World Stock

Camping World’s New Leadership Faces First Major Test

February 7, 2026
Viking Therapeutics Stock

Viking Therapeutics: Upcoming Financial Report to Guide Investor Sentiment

February 7, 2026
Diginex Stock

Diginex Enters Critical Implementation Phase Following Strategic Moves

February 7, 2026

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Follow us on social media:

Recent News

  • Universal Insurance Maintains Quarterly Payout Amid Sector Headwinds
  • Embecta’s Q1 Performance Outpaces Analyst Forecasts
  • Camping World’s New Leadership Faces First Major Test

Category

  • About
  • Advertise
  • Careers
  • Contact
  • Imprint
  • Privacy Policy
  • Terms of Service

© 2023 StocksToday.com

No Result
View All Result
  • Home
  • Tech & Software
  • Earnings
  • Analysis
  • Trading & Momentum
  • Cryptocurrency
  • Banking & Insurance
  • AI & Quantum Computing

© 2023 StocksToday.com